New life sciences investment company seeks to take advantage of depressed UK valuations
Investment company Conviction Life Sciences is hoping to raise up to £100 million via an initial public offering on the Main Market of the London Stock Exchange on 16 December.It is targeting 20% annualised growth in total net asset...
01 December 2022